Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysis

• Published in: Surgery Vol. 175; no. 6; pp. 1580 - 1586
• Main Authors: Wismans, Leonoor V., Suurmeijer, J. Annelie, van Dongen, Jelle C., Bonsing, Bert A., Van Santvoort, Hjalmar C., Wilmink, Johanna W., van Tienhoven, Geertjan, de Hingh, Ignace H., Lips, Daan J., van der Harst, Erwin, de Meijer, Vincent E., Patijn, Gijs A., Bosscha, Koop, Stommel, Martijn W., Festen, Sebastiaan, den Dulk, Marcel, Nuyttens, Joost J., Intven, Martijn P.W., de Vos-Geelen, Judith, Molenaar, I. Quintus, Busch, Olivier R., Koerkamp, Bas Groot, Besselink, Marc G., van Eijck, Casper H.J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2024
• Subjects: Aged; Carcinoma, Pancreatic Ductal - surgery; Carcinoma, Pancreatic Ductal - therapy; Chemoradiotherapy - adverse effects; Chemoradiotherapy - methods; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy - adverse effects; Neoadjuvant Therapy - methods; Netherlands - epidemiology; Pancreatic Fistula - epidemiology; Pancreatic Fistula - etiology; Pancreatic Fistula - prevention & control; Pancreatic Neoplasms - surgery; Pancreatic Neoplasms - therapy; Pancreaticoduodenectomy - adverse effects; Postoperative Complications - epidemiology; Postoperative Complications - etiology; Postoperative Complications - prevention & control; Preoperative Care - methods; Prospective Studies; Netherlands
• ISSN: 0039-6060; 1532-7361
• DOI: 10.1016/j.surg.2024.01.029

Postoperative pancreatic fistula remains the leading cause of significant morbidity after pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Preoperative chemoradiotherapy has been described to reduce the risk of postoperative pancreatic fistula, but randomized trials on neoadjuvant treatment in pancreatic ductal adenocarcinoma focus increasingly on preoperative chemotherapy rather than preoperative chemoradiotherapy. This study aimed to investigate the impact of preoperative chemotherapy and preoperative chemoradiotherapy on postoperative pancreatic fistula and other pancreatic-specific surgery related complications on a nationwide level. All patients after pancreatoduodenectomy for pancreatic ductal adenocarcinoma were included in the mandatory nationwide prospective Dutch Pancreatic Cancer Audit (2014–2020). Baseline and treatment characteristics were compared between immediate surgery, preoperative chemotherapy, and preoperative chemoradiotherapy. The relationship between preoperative chemotherapy, chemoradiotherapy, and clinically relevant postoperative pancreatic fistula (International Study Group of Pancreatic Surgery grade B/C) was investigated using multivariable logistic regression analyses. Overall, 2,019 patients after pancreatoduodenectomy for pancreatic ductal adenocarcinoma were included, of whom 1,678 underwent immediate surgery (83.1%), 192 (9.5%) received preoperative chemotherapy, and 149 (7.4%) received preoperative chemoradiotherapy. Postoperative pancreatic fistula occurred in 8.3% of patients after immediate surgery, 4.2% after preoperative chemotherapy, and 2.0% after preoperative chemoradiotherapy (P = .004). In multivariable analysis, the use of preoperative chemoradiotherapy was associated with reduced risk of postoperative pancreatic fistula (odds ratio, 0.21; 95% confidence interval, 0.03–0.69; P = .033) compared with immediate surgery, whereas preoperative chemotherapy was not (odds ratio, 0.59; 95% confidence interval, 0.25–1.25; P = .199). Intraoperatively hard, or fibrotic pancreatic texture was most frequently observed after preoperative chemoradiotherapy (53% immediate surgery, 62% preoperative chemotherapy, 77% preoperative chemoradiotherapy, P < .001). This nationwide analysis demonstrated that in patients undergoing pancreatoduodenectomy for pancreatic ductal adenocarcinoma, only preoperative chemoradiotherapy, but not preoperative chemotherapy, was associated with a reduced risk of postoperative pancreatic fistula. [Display omitted]